BioFlo 44025Recalls & reported problems
Navilyst Medical, Inc. · BioFlo Titanium Port with PASV Valve Technology (Non-Filled Suture Holes) and 8F x 63cm Polyurethane Catheter with ENDEXO Technology · Class 2 · Implant
All models of BioFlo (87)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI H965440250), received between Jul 19, 2017 and Oct 10, 2024 — classified as 3 injuries.
The most frequently reported specific device problem is “Aspiration Issue” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Aspiration Issue1
- Migration or Expulsion of Device1
Patient problems
- Bacterial Infection1
- Fever1
- No Known Impact Or Consequence To Patient1
- Swelling1
- Thrombosis/Thrombus1
- Unspecified Kidney or Urinary Problem1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
InjuryOct 10, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON OR ABOUT (B)(6) 2020, (B)(6) UNDERWENT PLACEMENT OF AN ANGIODYNAMICS BIOFLO PRODUCT, MODEL/CAT NUMBER: H965440250, LOT NUMBER 5591591. UPON INFORMATION AND BELIEF, THE DEVICE AT ISSUE WAS IMPLANTED BY DR. (B)(6), AT (B)(6) HOSPITAL - (B)(6), FOR CHEMOTHERAPY TREATMENT FOR PLAINTIFF'S TONSIL CANCER. ON OR ABOUT (B)(6) 2020, PLAINTIFF PRESENTED TO (B)(6) HOSPITAL- (B)(6), WITH A FEVER WHICH PROMPTED EVALUATION OF HIS CATHETER. THEN, (B)(6)'S MEDICAL TEAM DETERMINED THAT HIS PORT WAS INFECTED WITH 8 COLONIES OF COAGULASE-NEGATIVE STAPHYLOCOCCUS, WHICH RESULTED IN PLAINTIFF'S ACUTE KIDNEY INJURY, WHICH UPON INFORMATION AND BELIEF, WAS DIAGNOSED ON (B)(6) 2020, AND IT WAS ALSO DETERMINED THAT PLAINTIFF HAD AN OCCLUSIVE DEEP VENOUS THROMBOSIS WITHIN A PORTION OF THE RIGHT INTERNAL JUGULAR VEIN, WHICH, UPON INFORMATION AND BELIEF, WAS DIAGNOSED ON (B)(6) 2020. ON OR ABOUT (B)(6) 2020, (B)(6) WAS TRANSFERRED TO THE OPERATING ROOM AT (B)(6) HOSPITAL - (B)(6). UPON INFORMATION AND BELIEF, THE INFECTED PORT WAS THEN REMOVED BY HIS INTERVENTIONAL RADIOLOGIST. AS A RESULT OF HAVING THE BIOFLO IMPLANTED, (B)(6) HAS, ALLEGEDLY, EXPERIENCED SIGNIFICANT PAIN AND SUFFERING, HAS UNDERGONE ADDITION
Patient problems: Bacterial Infection; Fever; Thrombosis/Thrombus; Unspecified Kidney or Urinary Problem
MAUDE report 20417779 ↗InjuryNov 27, 2017Migration or Expulsion of Device; Migration or Expulsion of Device
AS REPORTED, THE PHYSICIAN HAD PLACED THE PORT INTO THE PATIENT AND CLOSED THE POCKET. WHEN THE PORT WAS FLUSHED, THE CATHETER DETACHED AND MIGRATED TO THE RIGHT ATRIUM. THE CATHETER WAS SNARED AND REMOVED WITHOUT DIFFICULTY. THE PORT WAS THEN REPLACED, AT THAT TIME.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 7060581 ↗InjuryJul 19, 2017Aspiration Issue; Aspiration Issue
DETAILS OF THE PROBLEM AS PROVIDED BY THE PATIENT ARE THAT A BIOFLO PORT WAS IMPLANTED ON (B)(6) 2017 AFTER AN OPERATION FOR RECTAL CANCER. MULTIPLE NURSES / NEEDLE STICKS WERE NEEDED TO ACCESS THE PORT ON (B)(6) FOR AN IV. THE PHYSICIAN WAS FINALLY ABLE TO ACCESS. ON MARCH 29, 4 NURSES AGAIN WERE NEEDED BEFORE ACCESS WAS OBTAINED TO DRAW BLOOD FROM THE PORT. AFTER THE MULTIPLE ATTEMPTS ON (B)(6), "THE PORT AREA WAS SORE AND VERY SWOLLEN." THE PORT WAS REMOVED ON (B)(6) 2017 AND WILL BE RETURNED TO ANGIODYNAMICS FOR EVALUATION.
Patient problems: Swelling
MAUDE report 6725652 ↗
Other PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR devices
- PowerPort M.R.I., Groshong 9808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR3 deaths834 reports
- PowerPort ClearVUE 1608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR18 deaths571 reports
- PowerPort ClearVUE 5608062Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR31 deaths542 reports
- PowerPort M.R.I., ChronoFlex 1808000Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR19 deaths513 reports
- PowerPort M.R.I., ChronoFlex 1808060Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR1 recall15 deaths383 reports
- PowerPort M.R.I., Groshong 1808560Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR10 deaths304 reports
- PowerPort M.R.I., ChronoFlex 1829500Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR6 deaths197 reports
- BardPort M.R.I. 0602680Bard Access Systems, Inc. · PORT & CATHETER, IMPLANTED, SUBCUTANEOUS, INTRAVASCULAR2 deaths179 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page